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Abstract
Background: Accurate predictors of neurological recovery after cervical spinal cord injury are needed. Particularly,
to tailor adequate rehabilitation plans. However, objective and quantifiable predictors are sparse.
Methods: Within the prospective European Multicenter Study about Spinal Cord Injury (EMSCI) registry, cervical
spinal cord injury patients are monitored at fixed follow up visits (2, 4, 12, 24, and 48 weeks after injury) clinically
and with ulnar nerve electroneurography. Associations of ulnar nerve compound muscle action potential
amplitudes (CMAP) with American Spinal Cord Injury Association (ASIA) impairment scale (AIS) grades over time
were analyzed using linear mixed modeling. Applying logistic regression, the prognostic value of within 4-week
ulnar nerve CMAP for 1-year AIS was analyzed. To account for missing data, (1) last observation carried forward and
(2) multiple imputation methods were applied. For model derivation, our centers’ cohort (EMSCI-HD) was analyzed.
For model validation the cohort of other centers (EMSCI-nonHD) was used.
Results: In the EMSCI-HD cohort, the median age (interquartile range (IQR)) was 52 (34–67) years. 58% were male.
The initial AIS distribution was: A = 31%, B = 17%, C = 30%, and D = 22%). In the EMSCI-nonHD cohort, the median
age was 49 (32–65) years. Compared to the EMSCI-HD cohort more patients were male (79%, p = 0.0034). The AIS
distribution was: A = 33%, B = 13%, C = 21%, and D = 33%).
In complete-case mixed model analyses (EMSCI-HD: n = 114; EMSCI-nonHD: n = 508) higher ulnar nerve CMAP were
associated with better AIS grades over the entire follow up period. In complete-case logistic regression (EMSCI-HD:
n = 90; EMSCI-nonHD: n = 444) higher ulnar nerve CMAP was an independent predictor of better AIS grades. The
odds ratio for within 4-week ulnar nerve CMAP to predict 1-year AIS grade D versus A-C in the EMSCI-HD cohort
was 1.24 per millivolt (confidence interval 1.07–1.44). The model was validated in an independent cervical spinal
cord injury (EMSCI-nonHD) cohort (odds ratio 1.09, confidence interval 1.03–1.17).
Conclusions: In cervical spinal cord injury, the consideration of early ulnar nerve CMAP improves prognostic
accuracy, which is of particular importance in patients with clinical grading uncertainties.
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Background
Early and accurate prediction of neurological recovery is
a major goal in the care of traumatic cervical spinal cord
injury (SCI) for (1) providing patients with a realistic
prognosis, (2) an effective and tailored rehabilitation
plan and (3) the correct risk stratification in clinical tri-
als. One very robust predictor of neurological recovery is
the baseline American Spinal Injury association impair-
ment scale (AIS) grade [12, 22, 26]. For traumatic cer-
vical SCI there are accurate model systems to predict
AIS conversions on the basis of the initial AIS grade
over a time period of 1 year [10]. Except for AIS D and
E patients (no room for improvement due to a ceiling ef-
fect of the scale), patients with more severe injuries at
baseline are generally less likely to convert to better AIS
grades [22]. However, early on AIS grading is quite unre-
liable/inaccurate due to (1) patient specific issues (e. g.
deteriorated conscious state) [2, 11, 16, 24] or (2)
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uncertainties of investigators in applying the correct AIS
grade [20, 21]. Not only but in particular for these situa-
tions, an objective and quantifiable parameter would
help to improve prognostic accuracy. Except for sensory
and motor evoked potentials - which often are not sim-
ple to apply and interpret in the acute setting - no such
parameter is currently available [4–7, 17]. Moreover, in-
dependent predictors, which improve prognostic accur-
acy of clinical grading (AIS) alone, were not extensively
analyzed.
Electroneurography (ENG) of the ulnar nerve is a
standard clinical technique, which is widely available, ro-
bust and mobile. The technique enables examiners to
make reliable measurements even under intensive care
conditions where patients with cervical SCI usually stay
for the first days to weeks after injury. Furthermore,
resulting parameters like compound muscle action po-
tential (CMAP) amplitudes or nerve conduction veloci-
ties (NCV) are easy to quantify. So far, one study
demonstrated that pathologic ulnar nerve ENG (i.e. re-
duced CMAP amplitudes) is associated with worse hand
function in cervical SCI. Motoneuron damage (motor
neuronopathy) within the anterior horn of the cervical
spinal cord was hypothesized as the underlying mechan-
ism. Except for worse hand function [3] and the possibil-
ity to discern between a central versus peripheral paresis
pattern [6], ulnar nerve ENG was not systematically ana-
lyzed in cervical SCI as predictor of neurological recov-
ery (AIS conversion) and its role as a surrogate marker
for axonal injury to corticospinal neurons within the cer-
vical spinal cord.
Using the Heidelberg cohort of the European multi-
center study about spinal cord injury (EMSCI) database
(http://www.emsci.org) as a derivation data set, we could
demonstrate that increased AIS completeness is associ-
ated with decreased ulnar nerve CMAP amplitudes.
Moreover, we could demonstrate that early on (within 4
weeks after injury) preserved ulnar nerve CMAP ampli-
tudes are an independent predictor of good neurological
recovery at 1 year after injury (AIS D versus A-C). Fi-
nally, we could validate our prediction model using the
total non-HD EMSCI dataset demonstrating robustness/
inferability to other SCI centers.
Methods
EMSCI database
The EMSCI database is a prospective registry of acute
SCI patients (http://www.emsci.org; ClinicalTrials.gov
Identifier: NCT01571531). In this registry, the recovery
of patients is followed up for a total of 1 year after the
incident traumatic or ischemic SCI in order to provide
the clinical basis for new interventional therapies [8].
Assessments take place at fixed time points after the in-
cident injury: very acute (within 2 weeks), acute I (4
weeks), acute II (12 weeks), acute III (24 weeks), and
chronic (48 weeks). At each visit patients are graded
clinically according to the AIS (part of the International
Standards for Neurological Classification of Spinal Cord
Injury (ISNCSI); Additional file 1: Table S1) [13, 15].
Eleven of 21 centers within the EMSCI-project addition-
ally collect ulnar nerve ENG data in the cervical SCI
population. The ENG recordings are standardized be-
tween the 11 participating EMSCI-centers with respect
to the montage of electrodes and stimulation parame-
ters. The study was approved by the local institutional
review boards/independent ethics committees of each
participating center. Informed consent was obtained be-
fore any study related procedure.
Data analysis and statistical analysis
For the derivation data set the EMSCI patients from Hei-
delberg were used (EMSCI-HD). Of those, only patients
with a cervical neurological level of injury (NLI) were in-
cluded (segments C1 to T1; n = 249). Furthermore, only
patients with at least one clinical AIS grading and one
ulnar nerve CMAP measurement were included in the
final derivation data set (n = 114). A linear repeated mea-
sures mixed model was fit to the data with ulnar nerve
CMAP amplitude as a continuous dependent variable
(SAS®, PROC MIXED). As independent fixed effects vari-
ables, the following categorical factors were used: AIS
(four levels: A to D), NLI (nine levels: C1-T1), visits (four
levels: very acute, acute I, acute II, acute III, chronic), the
interaction effect between AIS and NLI, and the inter-
action effect between AIS and visit. Moreover, age was en-
tered into the final model as continuous variable. The
model allowed a random intercept for each patient with
an unstructured covariance structure grouped by AIS. Fol-
low up visits were entered as a repeated measures effect
into the final regression model with a first order autore-
gressive covariance structure. For hypothesis generation,
the model was first fit for the right ulnar nerves. Hypoth-
esis tests were then performed on statistically significant
effects (alpha level < 0.05) using the same model and ulnar
CMAP values of left hands. Alpha levels of < 0.05 were
regarded as statistically significant.
As additional control for missing data we applied mul-
tiple imputation (n = 10) of the variables (ulnar CMAP,
AIS) assuming a missing at random data structure and a
non-monotone missingness pattern. Hence, a chained
equation method with full imputation of missing data
was applied (regression for CMAP and regression or or-
dinal logistic regression for AIS). Mixed model analysis
was then performed by each single imputation and over-
all fitted means were calculated (SAS®, PROC MI and
PROC MIANALYZE; STATA® ICE) [9, 19]. In case, all
CMAP measurements were missing, no imputations
were made (i.e. the observation was deleted).
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Once higher CMAP amplitudes were identified to be
associated with better neurological recovery, we de-
signed a logistic multivariable model in order to analyze
whether early ulnar CMAP amplitudes are an independ-
ent predictor of 1-year neurological recovery (SAS®,
PROC LOGISTIC). For this purpose, we defined the first
4 weeks after injury as the prediction time frame (visits
very acute and acute I). Primarily, we used the very acute
values as predictors. Only if the very acute visit values
were missing (AIS or CMAP or NLI), we used the acute
I values. For the 1-year endpoint we used a last observa-
tion carried forward approach (complete-case analysis
set). The outcome variable was dichotomized into AIS
A-C versus AIS D (with D indicating a “good”/“useful”
neurological outcome). The initial AIS grade was en-
tered into the model as categorical factor dichotomized
into motor complete (A and B) versus motor incomplete
(C and D). In the initial statistical analysis plan, ordinal
scaling (A = 0, B = 1, C = 2, D = 3) was favored. However,
all initial AIS D patients in the EMSCI-HD cohort were
still AIS D at the final follow up visit (ceiling effect of
the AIS). Hence, a separate category for AIS D would
have been uninformative due to a perfect prediction of
the final AIS (D versus A-C). The CMAP amplitude was
entered into the model as continuous variable. Further-
more, NLI and age were entered in the first step of the
model. Using a backward variable elimination approach
(alpha level of < 0.05 to stay in the model) the following
variables were retained in the final model: initial AIS
and CMAP amplitude. First, we analyzed the logistic
model for the right hand. For hypothesis generation
alpha levels of < 0.05 were regarded as statistically sig-
nificant. For hypothesis testing, the significant effects
were then reanalyzed for the left hand using the same
model. Alpha levels of < 0.05 were regarded statistically
significant. ROC curves were generated and compared
via a bootstrap approach and plotted for each independ-
ent variable separately (pROC, R) [18]. Predicted prob-
abilities of the full logistic model were used to plot the
final model ROC curve. For differences in ROC curve
areas under the curve (AUC) an alpha level < 0.05 was
regarded statistically significant.
Due to missing data we also investigated the results of
the logistic model with the use of multiple imputation.
In case all CMAP measurements were missing, no impu-
tations were made (i.e. observation was deleted). After
full imputation n = 120 patients contributed to the
model. A total of 10 data sets were imputed and after-
wards an overall mean of the estimates with correspond-
ing 95%-confidence intervals were calculated (SAS®,
PROC MI and PROC MIANALYZE).
For validation of the logistic prediction model, the EMSCI
data set of other centers was used (EMSCI-nonHD). Data
management was equivalent to the EMSCI-HD dataset. Due
to side symmetrical results for right and left ulnar nerves,
data are presented only for the right ulnar nerves.
Data management and statistical analysis was per-
formed using SAS® version 9.2, Stata® version 11 and R
version 2.15.2.
Results
Derivation data set. Demographic and clinical data
Over a recruiting period of 11 years (2001–2012) we iden-
tified 249 patients with cervical SCI (NLI C1-T1) in the
EMSCI-HD cohort. Of those, 114 patients had sufficient
data (at least one AIS grade and one ulnar CMAP meas-
urement) for mixed model analysis. For logistic regression,
90 patients had sufficient data for complete-case statistical
analysis (i.e., one AIS grading and one CMAP measure-
ment within 4 weeks; last observation carried forward) in
the EMSCI-HD cohort. Using multiple imputation, obser-
vations of 120 patients were informative for statistical ana-
lysis. For the complete-case data set age (median,
interquartile range (IQR)) was 52 (34–67) years. Male to
female ratio was 58/32 (Baseline clinical characteristics
are given in Table 1). The distribution of the NLI revealed
an expected maximum at the cervical levels C4 and C5
(Fig. 1a). The AIS conversion rates showed the typical pat-
tern with more complete patients (AIS A) converting less
likely to better AIS grades than less complete patients
(AIS B, C; ceiling effect of the scale for AIS D) (Fig. 1b).
Derivation data set. Mixed model analysis of ulnar nerve
CMAP association with AIS grade over time
The ulnar nerve CMAP amplitude lower limit of normal
in our neurophysiology laboratory is 5.6 mV. With re-
spect to this limit, patients with AIS A-C exhibited bor-
derline or decreased CMAP amplitudes over the total
follow up period of 1 year. In contrast, patients with AIS
D revealed CMAP amplitudes within normal limits over
the entire follow up period (Fig. 2a).
In contrast to AIS D patients AIS A-C patients devel-
oped a drop of CMAP amplitudes from very acute to
acute I and II time points (Fig. 2a).
Derivation data set. Logistic model using initial AIS/CMAP
to predict functional outcome at 1 year
Sufficient data for the complete-case statistical analysis
was available in n = 90 patients. As expected, the main
predictor of good outcome in multivariable logistic
model was the initial AIS grade (dichotomized C-D ver-
sus A-B) with an OR of 37.61 (CI 9.49–149.03, p <
0.0001). Furthermore, logistic model analysis revealed
that higher initial CMAP amplitudes were an independ-
ent predictor of good 1-year outcome (AIS D versus
A-C). The OR per mV increase in CMAP amplitude was
1.24 (CI 1.07–1.44, p = 0.0025). The combination of AIS
and CMAP amplitude performed better with respect to
Hug et al. Neurological Research and Practice            (2019) 1:11 Page 3 of 8
Table 1 Complete-case data set
EMSCI-HD EMSCI-nonHD p value
N = 90 n = 444
Age (median years, IQR) 52 (34–67) 49 (32–65) 0.1678
Gender (count male, %) 58 (64.44) 350 (78.83) 0.0034
AIS initial (count, %) 0.0897
A 28 (31.11) 145 (32.66)
B 15 (16.67) 59 (13.29)
C 27 (30.00) 92 (20.72)
D 20 (22.22) 148 (33.33)
AIS end (count, %) 0.2301
A 22 (24.44) 88 (19.82)
B 15 (16.67) 55 (12.39)
C 13 (14.44) 51 (11.49)
D 40 (44.44) 250 (56.31)
Timing of visits (median weeks, IQR)
Very acute 1.21 (0.86–1.71) 1.0 (0.43–1.57) 0.5871
Acute I 4.07 (3.57–4.64) 4.14 (3.57–4.71) 0.8436
Acute II 12.0 (11.29–12.29) 12.0 (11.57–12.71) 0.4226
Acute III 23.93 (22.86–24.29) 24.0 (23.29–25.0) 0.4665
Chronic 50.86 (45.0–56.86) 48.42 (46.92–52.29) < 0.0001
p<0.05 values are typed bold
A
B
C
D
Fig. 1 a NLI distribution (b) AIS conversions of the EMSCI-HD cohort. c NLI distribution (d) AIS conversions of the EMSCI-nonHD cohort.
Complete-case analysis: EMSCI-HD n = 90; EMSCI-nonHD n = 444
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prediction accuracy than initial AIS alone as demon-
strated by ROC curve analysis (Fig. 3a; for CMAP ampli-
tude alone see Additional file 1: Figure S1). The
difference between AUC of the AIS model (0.85; CI
0.78–0.92) compared to the AIS + CMAP model (0.92;
CI 0.87–0.97) was statistically significant (p = 0.0017).
Sensitivity and Specificity of the AIS + CMAP model for
the prediction of 1-year outcome was 0.88 and 0.84, re-
spectively. After multiple imputation a total of 120 pa-
tients were available for analysis. Results were similar to
the complete-case analysis of the unimputed data set:
OR 1.24, CI 1.03–1.48 (Additional file 1: Table S2).
Validation data set
Demographic data was similar in the EMSCI-HD and
EMSCI-nonHD data sets except for a slight preponderance
of male patients in the EMSCI-nonHD cohort (Table 1).
NLI distributions and AIS-conversions rates of the
EMSCI-nonHD cohort are given in Fig. 1c and d.
Re-analysis of the mixed model in the EMSCI-nonHD data
set (n = 508) revealed similar results as for the EMSCI-HD
cohort (Fig. 2b). Using the complete-case data set a total of
444 cases were informative for logistic regression analysis.
Using the same logistic model as for the EMSCI-HD co-
hort, re-analysis in the EMSCI-nonHD cohort also re-
vealed that baseline ulnar CMAP predicted good outcome
(AIS D versus A-C) with an OR of 1.09 per mV CMAP
amplitude increase (CI 1.03–1.17, p = 0.006). Compared to
AIS alone the combination of AIS +CMAP revealed an
improved prediction accuracy as demonstrated by ROC
curve analysis (0.87 CI 0.84–0.9 versus 0.90 CI 0.87–0.93;
p = 0.0003 for AUC difference; Fig. 3b). After multiple im-
putation (n = 10 imputations) 508 patients were
informative for statistical analysis. Again, baseline ulnar
CMAP was predictive for good outcome (AIS D versus
A-C) with an OR of 1.10 per mV CMAP amplitude in-
crease (CI 1.04–1.18, p = 0.0022). For logistic regression re-
sults see Additional file 1: Table S3. AIS-conversion rates
for the complete-case and multiple imputation datasets are
visualized in Additional file 1: Figure S2.
Discussion
For patients with acute cervical SCI we could demon-
strate (1) a positive correlation of ulnar nerve CMAP
amplitudes with AIS incompleteness over time. (2)
Within 4-week ulnar nerve axonal integrity is an inde-
pendent predictor of good 1-year outcome. (3) The pre-
diction model consisting of baseline AIS and ulnar nerve
CMAP amplitude is robust and inferable to other cer-
vical SCI cohorts.
This is the first clinical study, which demonstrates that
a readily measurable and quantifiable damage to the per-
ipheral nervous system (ulnar nerve CMAP measure-
ments) is a useful surrogate marker for central nervous
system recovery (AIS grade) after cervical SCI. The
underlying pathomechanism of reduced ulnar nerve
CMAP amplitudes after acute cervical SCI remains only
incompletely understood. The identified time course
with an amplitude nadir not at the very acute (2 weeks)
but later time points argues for an ongoing neuronal/
axonal degeneration (e.g. Wallerian degeneration of
lower motoneurons). Data supporting this theory come
from one study where it was shown that lower ulnar
nerve CMAP amplitudes in patients with low cervical
NLI (C8/T1) are associated with worse hand function.
There, it was hypothesized, that reduced ulnar CMAP
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Fig. 2 a Mixed model estimates of means and 95% confidence intervals of right ulnar CMAP amplitudes in the EMSCI-HD cohort over the 1-year
follow up. b Mixed model estimates of means and 95% confidence intervals of right ulnar CMAP amplitudes in the EMSCI-nonHD cohort over the
1-year follow up
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amplitudes may be due to lower motoneuron damage
[3]. To decipher the underlying pathomechanism in clin-
ical SCI, further investigations are warranted. For this
purpose, very early screening (day 1) with daily monitor-
ing of Wallerian degeneration would be necessary. Pos-
sibly, the difference between baseline ulnar nerve CMAP
and the CMAP after Wallerian degeneration might be
an even better marker for lower motoneuron damage.
Regardless of the underlying mechanism for reduced
ulnar CMAP amplitudes, they also seem to reflect
axonal damage to upper (corticospinal) motoneurons
since increased AIS completeness and not the NLI was
the main predictor for low CMAP amplitudes in our
analyses. A recent MRI study supports this idea, with
more AIS complete injuries associated with an increased
intramedullary length of lesion [1]. Formally it remains
to be established, if decreased ulnar CMAP amplitudes
are a mere indicator for ventral horn (lower moto-
neuron) damage, or could also serve as a surrogate
marker for axonal damage of corticospinal motoneurons.
The fact of an association with neurological recovery
(measured by AIS grade) in our study, argues for the
suitability as such a surrogate marker. The most accur-
ate cut-off value of ulnar nerve CMAP amplitudes for
the prediction of neurological outcome was not explicitly
addressed in this study. However, the lower limit of
A
B
Fig. 3 ROC curve analysis of logistic regression results. The solid line represents the logistic fit of the initial AIS (within first 4 weeks) for the prediction
of good recovery AIS D versus A-C. The dashed line represents the logistic model fit of initial AIS + initial right ulnar nerve CMAP amplitude. The
improved prediction accuracy of the full model (initial AIS + initial CMAP) versus initial AIS alone is significant in the EMSCI-HD (a) and EMSCI-nonHD
(b) cohorts, respectively (p = 0.0017 and 0.0003). Complete-case analysis. (EMSCI-HD cohort n = 90; EMSCI-nonHD cohort n = 444)
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ulnar nerve CMAP amplitude at our site (5.6 mV) seems
to be a suitable value as demonstrated by our mixed
model analysis.
Except for accurate early prognosis and planning of re-
habilitation interventions, early on measurements of ulnar
nerve CMAP amplitudes could help to improve risk strati-
fication in randomized clinical trials of SCI. Such accurate
stratification is of utmost importance in acute SCI trials to
balance baseline variables since slow recruitment is a
major problem and treatment effects of novel experimen-
tal drugs are usually small [10, 14, 23, 25].
A further advantage of ulnar nerve CMAP measure-
ments is the easy and objective application even in the
intensive care setting, where patients usually are only
partly cooperative [2, 11, 16, 24]. Furthermore, subject-
ive errors due to uncertainties of the correct AIS appli-
cation [20, 21] could be partly compensated by the
added prognostic value of CMAP measurements.
Our analysis has several limitations. First of all, the data
contain many missing values. We addressed this problem
by different methods, i.e. linear mixed model, last observa-
tion carried forward and multiple full imputation analysis.
Due to the robustness of the detected effects across the
different analysis sets, we are confident that the CMAP ef-
fect truly exists. Furthermore, our analysis was based on
the so far largest sample size with regards to the prognos-
tic significance of ulnar nerve CMAP amplitudes. A fur-
ther weakness is the possibility of a systematic bias
regarding missing CMAP measurements in more severe
SCI patients. Analyses of missing case patterns however,
suggested a missing at random data pattern. Due to the
study design, inference is limited to the spinal segments
C8-T1 (ulnar nerve). Considering the more extensive
range of spinal segments, CMAP amplitudes of median
nerves (C5-T1) might be more accurate surrogate predic-
tors of neurological outcome. Due to the time course of
Wallerian degeneration, electroneurography will probably
not be a useful prognostic predictor for ultra-early stages
of SCI (i.e., hours after injury). For these ultra-early time
windows where clinical AIS grading becomes more and
more inaccurate, other surrogate markers to decipher
spinal shock with and without permanent spinal cord in-
jury are urgently needed for surgical/medical
decision-making [27]. Our data is representative for
Mid-European SCI patients and care facilities. Inferability
to other parts of the world needs to be demonstrated.
Conclusions
The consideration of early ulnar nerve CMAP ampli-
tudes improves prognostic accuracy of 1-year neurologic
outcomes in cervical SCI patients. This could be of par-
ticular importance in patients who are difficult to grade
clinically. Moreover, improved accuracy could prove sig-
nificant for proper risk stratification in clinical trials.
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